1-10 of 10
Christine Mayr
Close
Sort by
Journal Articles

3' Untranslated Region (UTR) Alterations Are Frequently Targeted By MM-Related Mirnas and Affects the Clinical Outcome

Mehmet K. Samur, PhD, Irtisha Singh, Lee Shih-Han, Adam Samuel Sperling, MD PhD, Mariateresa Fulciniti, PhD, Yu-Tzu Tai, PhD, Giovanni Parmigiani, PhD, Christina S. Leslie, PhD, Christine Mayr, Nikhil C Munshi, MD
Journal: Blood
Blood (2016) 128 (22): 4447.
https://doi.org/10.1182/blood.V128.22.4447.4447
Published: 2016
Journal Articles

Global 3' UTR Sequencing in Multiple Myeloma (MM)

Irtisha Singh, Mehmet K Samur, PhD, Lee Shih-Han, Adam Samuel Sperling, MD PhD, Yu-Tzu Tai, PhD, Mariateresa Fulciniti, Christina S Leslie, PhD, Christine Mayr, Nikhil C. Munshi, MD
Journal: Blood
Blood (2015) 126 (23): 2994.
https://doi.org/10.1182/blood.V126.23.2994.2994
Published: 2015
Journal Articles

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

Christian P Pallasch, MD, Michaela Patz, PhD, Yoon Jung Park, PhD, Susanne Hagist, MD, Daniela Eggle, PhD, Rainer Claus, MD, Svenja Debey-Pascher, PhD, Alexandra Schulz, Lukas P Frenzel, MD, Julia Claasen, Nadine Kutsch, Günter Krause, PhD, Christine Mayr, MD, Andreas Rosenwald, MD, Christoph Plass, PhD, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2009) 114 (22): 3463.
https://doi.org/10.1182/blood.V114.22.3463.3463
Published: 2009
Journal Articles

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Christian Philipp Pallasch, Michaela Patz, Yoon Jung Park, Susanne Hagist, Daniela Eggle, Rainer Claus, Svenja Debey-Pascher, Alexandra Schulz, Lukas P. Frenzel, Julia Claasen, Nadine Kutsch, Günter Krause, Christine Mayr, Andreas Rosenwald, Christoph Plass, Joachim L. Schultze, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2009) 114 (15): 3255–3264.
https://doi.org/10.1182/blood-2009-06-229898
Published: 2009
Includes: Supplemental data
Journal Articles

Occurrence of Chromosomal Translocations as Independent Prognostic Factor in Chronic Lymphocytic Leukemia.

Christine Mayr, MD, Cathrine Schulz, M.D., Stephan Stilgenbauer, M.D., Alexander Kröber, M.D., Hartmut Döhner, M.D., Ulrich Jäger, M.D., Birgit Kainz, M.D., Georg Hopfinger, M.D., Rüdiger Hoffmann, M.D., Clemens Wendtner, M.D., Michael Hallek, M.D., Michael R. Speicher, M.D.
Journal: Blood
Blood (2006) 108 (11): 2084.
https://doi.org/10.1182/blood.V108.11.2084.2084
Published: 2006
Journal Articles

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia

Clinical Trials & Observations
Christine Mayr, Michael R. Speicher, David M. Kofler, Raymund Buhmann, John Strehl, Raymonde Busch, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2006) 107 (2): 742–751.
https://doi.org/10.1182/blood-2005-05-2093
Published: 2006
Journal Articles

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

Brief Report
Christine Mayr, David M. Kofler, Hildegard Büning, Dagmar Bund, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2005) 106 (9): 3223–3226.
https://doi.org/10.1182/blood-2005-04-1742
Published: 2005
Journal Articles

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes

Christine Mayr, Dagmar Bund, Martin Schlee, Andreas Moosmann, David M. Kofler, Michael Hallek, Clemens-Martin Wendtner
Journal: Blood
Blood (2005) 105 (4): 1566–1573.
https://doi.org/10.1182/blood-2004-04-1233
Published: 2005
Journal Articles

High Incidence of Translocations in CLL: A New Prognostic Marker for Infavorable Survival Outcome.

Christine Mayr, MD, David M. Kofler, MD, Raymund Buhmann, MD, John Strehl, MD, Raymonde Busch, Michael Hallek, MD, Clemens-Martin Wendtner, MD
Journal: Blood
Blood (2004) 104 (11): 17.
https://doi.org/10.1182/blood.V104.11.17.17
Published: 2004
Journal Articles

Fibromodulin as a Novel Tumor-Associated Antigen (TAA) in Chronic Lymphocytic Leukemia (CLL) Which Allows Expansion of Specific CD8+ Autologous T Lymphocytes.

Christine Mayr, MD, Dagmar Bund, Martin Schlee, PhD, Andreas Moosmann, PhD, Michael Hallek, MD, Clemens Wendtner, MD
Journal: Blood
Blood (2004) 104 (11): 175.
https://doi.org/10.1182/blood.V104.11.175.175
Published: 2004